When was Huajin Securities Investment founded?

Huajin Securities Investment was founded in 2019.

Where is Huajin Securities Investment headquartered?

Huajin Securities Investment is headquartered in Shanghai, China.

How many investments has Huajin Securities Investment made?

Huajin Securities Investment has made 11 investments.

What has Huajin Securities Investment invested in?

Huajin Securities Investment has made numerous investments in companies like Mira Innovation Technology , Zhuhai Jexin Semiconductor , and Biovision (Drug Discovery) within the Diagnostic Equipment, Electronic Equipment and Instruments, and Drug Discovery industries.

What has Huajin Securities Investment invested in recently?

Huajin Securities Investment's latest investment was on 16-Sep-2025 in Mira Innovation Technology , a company within the Diagnostic Equipment industry.

Huajin Securities Investment investment portfolio

Huajin Securities Investment Overview

Investor Type

Venture Capital

Status

Active

Investments

11

Portfolio

9

Exits

2

Huajin Securities Investment General Information

Company Description

Founded in 2019, Huajin Securities Investment is a corporate venture capital arm of Huajin Securities Company based in Shanghai, China.

Business Details

Year Founded

2019

Investor Status

Actively Seeking New Investments

Primary Investor Type

Corporate Venture Capital

Corporate Office

Building 2
Number 692 Yongjia Road, Xuhui District
Shanghai
China

Huajin Securities Investment Investments (11)

Company Name	Deal Date	Deal Type	Industry	Company Stage
Mira Innovation Technology	16-Sep-2025	Early Stage VC	Diagnostic Equipment	Generating Revenue
Zhuhai Jexin Semiconductor	07-Mar-2025		Electronic Equipment and Instruments	Startup
Biovision (Drug Discovery)	22-Jul-2024		Drug Discovery	Generating Revenue
Zhenshan Science and Technology	31-May-2024		Application Software	Profitable
AnDiConBio	23-Apr-2024		Drug Discovery	Generating Revenue
Weimu Medical	23-Nov-2023		Pharmaceuticals	Generating Revenue
Zhuhai Trinomab Pharmaceutical	17-Apr-2023		Drug Discovery	Generating Revenue
Guangzhou Innogen Pharmaceutical Group Co	15-Feb-2023		Pharmaceuticals	Clinical Trials - General
Summit Crystal	20-Dec-2022	Early Stage VC	Specialty Chemicals	Generating Revenue
Fatri	01-Jul-2022	Later Stage VC	General Purpose Semiconductors	Generating Revenue

You’re viewing 10 of 11 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Huajin Securities Investment Exits (2)

Company Name	Exit Date	Exit Type	Exit Size
Zhuhai Trinomab Pharmaceutical	21-Jul-2026	IPO
Guangzhou Innogen Pharmaceutical Group Co	14-Aug-2025

To view Huajin Securities Investment’s complete exits history, request access »

Huajin Securities Investment Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.